胸膜内注射米托蒽醌用于恶性胸腔积液的姑息治疗。
Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions.
作者信息
Morales M, Expósito M C
机构信息
Department of Medicine, Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Canary Islands, Spain.
出版信息
Support Care Cancer. 1995 Mar;3(2):147-9. doi: 10.1007/BF00365856.
PMID:7539702
Abstract
A group of 21 patients with malignant pleural effusions were treated with the instillation of 40 mg mitoxantrone intrapleurally, after complete fluid drainage. There was a 100% complete response rate with no toxic effects (0%). The mean survival of the patients was 57.1 weeks.
摘要
一组21例恶性胸腔积液患者在胸腔积液完全引流后，经胸腔内注入40毫克米托蒽醌进行治疗。完全缓解率为100%，且无毒性反应（0%）。患者的平均生存期为57.1周。
Zotero 插件